Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-01-09
1987-10-13
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548252, C07D21306, C07D27724, A61K 31425, A61K 3139
Patent
active
046999175
ABSTRACT:
Novel 6H-dibenz[b,e][1,4]oxathiepin derivatives of the formulae I and Ia are employed in the treatment and control of allergic conditions such as allergic asthma. ##STR1##
REFERENCES:
patent: 4091108 (1978-05-01), Batchelor et al.
patent: 4103015 (1978-07-01), Hodson et al.
patent: 4582842 (1986-04-01), Cragoe et al.
Cragoe, Jr. Edward J.
Rokach Joshua
Rooney Clarence S.
Caruso Charles M.
Jiles Henry R.
Merck & Co. , Inc.
Mullins J. G.
Pfeiffer Hesna J.
LandOfFree
Anti-asthmatic tetrazolyl 6H-dibenz-[B,E]-[1,4]-oxathiepin deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-asthmatic tetrazolyl 6H-dibenz-[B,E]-[1,4]-oxathiepin deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-asthmatic tetrazolyl 6H-dibenz-[B,E]-[1,4]-oxathiepin deriv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-411621